Related Experiment Videos
Proton magnetic resonance spectroscopy with dementia
A Shiino1, M Matsuda, S Morikawa
1Department of Neurosurgery, Shiga University of Medical Science, Japan.
Surgical Neurology
|February 1, 1993
Summary
Proton magnetic resonance spectroscopy revealed reduced N-acetylaspartate to creatine ratios in dementia patients, indicating potential neuronal loss. This technique may aid early dementia detection and study.
Area of Science:
- Neuroscience
- Biochemistry
- Medical Imaging
Background:
- Metabolic changes in the brain are crucial for understanding dementia.
- In vivo localized proton magnetic resonance spectroscopy (1H-MRS) offers insights into brain metabolism.
Purpose of the Study:
- To investigate brain metabolic alterations in dementia using 1H-MRS.
- To assess the diagnostic potential of specific metabolic ratios for primary degenerative dementia.
Main Methods:
- Localized 1H-MRS was performed on patients with primary degenerative dementia and normal-pressure hydrocephalus, compared to healthy volunteers.
- Regional cerebral blood flow was measured using single-photon emission computed tomography.
- Analysis focused on the ratio of N-acetylaspartate (NAA) to creatine (Cr) and phosphocreatine (Cr).
Main Results:
- A significantly reduced NAA/Cr ratio was observed in primary degenerative dementia patients.
- This reduction was present even without significant brain atrophy or decreased cerebral blood flow.
- Patients with normal-pressure hydrocephalus did not show a significant reduction in the NAA/Cr ratio.
Conclusions:
- The NAA/Cr ratio may serve as a biomarker for neuronal cell number and/or activity.
- 1H-MRS shows promise as a tool for early dementia detection.
- This technique can facilitate further pathophysiological studies of primary degenerative dementia.